U.S. Markets open in 6 hrs 4 mins
  • S&P Futures

    4,399.25
    +5.50 (+0.13%)
     
  • Dow Futures

    34,930.00
    +96.00 (+0.28%)
     
  • Nasdaq Futures

    15,008.50
    -3.00 (-0.02%)
     
  • Russell 2000 Futures

    2,233.80
    +13.10 (+0.59%)
     
  • Crude Oil

    73.06
    +0.67 (+0.93%)
     
  • Gold

    1,818.60
    +18.90 (+1.05%)
     
  • Silver

    25.47
    +0.59 (+2.36%)
     
  • EUR/USD

    1.1874
    +0.0027 (+0.2256%)
     
  • 10-Yr Bond

    1.2610
    0.0000 (0.00%)
     
  • Vix

    18.31
    -1.05 (-5.42%)
     
  • GBP/USD

    1.3950
    +0.0041 (+0.2957%)
     
  • USD/JPY

    109.8200
    -0.0900 (-0.0819%)
     
  • BTC-USD

    40,041.27
    +326.10 (+0.82%)
     
  • CMC Crypto 200

    937.51
    +7.59 (+0.82%)
     
  • FTSE 100

    7,049.59
    +32.96 (+0.47%)
     
  • Nikkei 225

    27,782.42
    +200.76 (+0.73%)
     

Regeneron says its COVID-19 antibody treatment cuts the risk of death among hospitalized patients

·1 min read
Regeneron says its COVID-19 antibody treatment cuts the risk of death among hospitalized patients

Shares of Regeneron Pharmaceuticals Inc. gained 0.1% in premarket trading on Wednesday after the company said its COVID-19 antibody therapy cut the risk of death in patients who have been hospitalized by 20%. This is the first time clinical research has demonstrated that Regeneron's antibody treatment has improved survival for hospitalized patients. The study, which is being conducted in the U.K. in patients who have not yet developed antibodies, follows other research that showed the company's